PharmaShots | Incisive News in 3 Shots

Subscribe Now

Influenza Virus

Shionogi Receives MHLW's Approval for Xofluza's sNDA to Treat Post-Exposure Prophylaxis of Influenza Virus Infection

Shionogi Receives MHLW's Approval for Xofluza's sNDA to Treat Post-Exposure Prophylaxis of Influenza Virus Infection

November 30, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us